FDA NDC Directory · JSON-LD · Markdown

XELJANZ

NDC 0069-1029 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nametofacitinib
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA213082
Dosage form / routeSOLUTION · ORAL
Active ingredientsTOFACITINIB CITRATE (1 mg/mL)
Marketing started20210208
Package count1

External sources

Source: openFDA. Public-domain (CC0).